Plasma levels of the MMP-9:TIMP-1 complex as prognostic biomarker in breast cancer: a retrospective study

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Plasma levels of the MMP-9:TIMP-1 complex as prognostic biomarker in breast cancer : a retrospective study. / Thorsen, Stine Buch; Christensen, Sarah Louise T; Würtz, Sidse Ørnbjerg; Lundberg, Martin; Nielsen, Birgitte Egedie Sander; Jensen, Lena Vinther; Knowles, Mick; Gee, Nick; Fredriksson, Simon; Møller, Susanne; Brünner, Nils; Rasmussen, Anne-Sofie Schrohl; Stenvang, Jan.

In: B M C Cancer, Vol. 13, 598, 2013.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Thorsen, SB, Christensen, SLT, Würtz, SØ, Lundberg, M, Nielsen, BES, Jensen, LV, Knowles, M, Gee, N, Fredriksson, S, Møller, S, Brünner, N, Rasmussen, A-SS & Stenvang, J 2013, 'Plasma levels of the MMP-9:TIMP-1 complex as prognostic biomarker in breast cancer: a retrospective study', B M C Cancer, vol. 13, 598. https://doi.org/10.1186/1471-2407-13-598

APA

Thorsen, S. B., Christensen, S. L. T., Würtz, S. Ø., Lundberg, M., Nielsen, B. E. S., Jensen, L. V., Knowles, M., Gee, N., Fredriksson, S., Møller, S., Brünner, N., Rasmussen, A-S. S., & Stenvang, J. (2013). Plasma levels of the MMP-9:TIMP-1 complex as prognostic biomarker in breast cancer: a retrospective study. B M C Cancer, 13, [598]. https://doi.org/10.1186/1471-2407-13-598

Vancouver

Thorsen SB, Christensen SLT, Würtz SØ, Lundberg M, Nielsen BES, Jensen LV et al. Plasma levels of the MMP-9:TIMP-1 complex as prognostic biomarker in breast cancer: a retrospective study. B M C Cancer. 2013;13. 598. https://doi.org/10.1186/1471-2407-13-598

Author

Thorsen, Stine Buch ; Christensen, Sarah Louise T ; Würtz, Sidse Ørnbjerg ; Lundberg, Martin ; Nielsen, Birgitte Egedie Sander ; Jensen, Lena Vinther ; Knowles, Mick ; Gee, Nick ; Fredriksson, Simon ; Møller, Susanne ; Brünner, Nils ; Rasmussen, Anne-Sofie Schrohl ; Stenvang, Jan. / Plasma levels of the MMP-9:TIMP-1 complex as prognostic biomarker in breast cancer : a retrospective study. In: B M C Cancer. 2013 ; Vol. 13.

Bibtex

@article{c07e5b1064af45d599443641cbf47185,
title = "Plasma levels of the MMP-9:TIMP-1 complex as prognostic biomarker in breast cancer: a retrospective study",
abstract = "Worldwide more than one million women are annually diagnosed with breast cancer. A considerable fraction of these women receive systemic adjuvant therapy; however, some are cured by primary surgery and radiotherapy alone. Prognostic biomarkers guide stratification of patients into different risk groups and hence improve management of breast cancer patients. Plasma levels of Matrix Metalloproteinase-9 (MMP-9) and its natural inhibitor Tissue inhibitor of metalloproteinase-1 (TIMP-1) have previously been associated with poor patient outcome and resistance to certain forms of chemotherapy. To pursue additional prognostic information from MMP-9 and TIMP-1, the level of the MMP-9 and TIMP-1 complex (MMP-9:TIMP-1) was investigated in plasma from breast cancer patients.",
author = "Thorsen, {Stine Buch} and Christensen, {Sarah Louise T} and W{\"u}rtz, {Sidse {\O}rnbjerg} and Martin Lundberg and Nielsen, {Birgitte Egedie Sander} and Jensen, {Lena Vinther} and Mick Knowles and Nick Gee and Simon Fredriksson and Susanne M{\o}ller and Nils Br{\"u}nner and Rasmussen, {Anne-Sofie Schrohl} and Jan Stenvang",
year = "2013",
doi = "10.1186/1471-2407-13-598",
language = "English",
volume = "13",
journal = "B M C Cancer",
issn = "1471-2407",
publisher = "BioMed Central Ltd.",

}

RIS

TY - JOUR

T1 - Plasma levels of the MMP-9:TIMP-1 complex as prognostic biomarker in breast cancer

T2 - a retrospective study

AU - Thorsen, Stine Buch

AU - Christensen, Sarah Louise T

AU - Würtz, Sidse Ørnbjerg

AU - Lundberg, Martin

AU - Nielsen, Birgitte Egedie Sander

AU - Jensen, Lena Vinther

AU - Knowles, Mick

AU - Gee, Nick

AU - Fredriksson, Simon

AU - Møller, Susanne

AU - Brünner, Nils

AU - Rasmussen, Anne-Sofie Schrohl

AU - Stenvang, Jan

PY - 2013

Y1 - 2013

N2 - Worldwide more than one million women are annually diagnosed with breast cancer. A considerable fraction of these women receive systemic adjuvant therapy; however, some are cured by primary surgery and radiotherapy alone. Prognostic biomarkers guide stratification of patients into different risk groups and hence improve management of breast cancer patients. Plasma levels of Matrix Metalloproteinase-9 (MMP-9) and its natural inhibitor Tissue inhibitor of metalloproteinase-1 (TIMP-1) have previously been associated with poor patient outcome and resistance to certain forms of chemotherapy. To pursue additional prognostic information from MMP-9 and TIMP-1, the level of the MMP-9 and TIMP-1 complex (MMP-9:TIMP-1) was investigated in plasma from breast cancer patients.

AB - Worldwide more than one million women are annually diagnosed with breast cancer. A considerable fraction of these women receive systemic adjuvant therapy; however, some are cured by primary surgery and radiotherapy alone. Prognostic biomarkers guide stratification of patients into different risk groups and hence improve management of breast cancer patients. Plasma levels of Matrix Metalloproteinase-9 (MMP-9) and its natural inhibitor Tissue inhibitor of metalloproteinase-1 (TIMP-1) have previously been associated with poor patient outcome and resistance to certain forms of chemotherapy. To pursue additional prognostic information from MMP-9 and TIMP-1, the level of the MMP-9 and TIMP-1 complex (MMP-9:TIMP-1) was investigated in plasma from breast cancer patients.

U2 - 10.1186/1471-2407-13-598

DO - 10.1186/1471-2407-13-598

M3 - Journal article

C2 - 24330623

VL - 13

JO - B M C Cancer

JF - B M C Cancer

SN - 1471-2407

M1 - 598

ER -

ID: 98037944